phenazepam has been researched along with Anxiety Disorders in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (75.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Bedina, IA; Brun, EA; Buzik, OZ; Chumakov, EM; Grishina, EA; Petrovna, A; Ryzhikova, KA; Savchenko, LM; Skryabin, VY; Sorokin, AS; Sychev, DA; Torrado, M; Zastrozhin, MS | 1 |
| Antonenko, AP; Bryun, EA; Esakova, AP; Grishina, EA; Mustafina, VR; Nesterenko, EV; Savchenko, LM; Seyfullaeva, LI; Skryabin, VY; Sorokin, AS; Sychev, DA; Zastrozhin, MS | 1 |
| Agibalova, TV; Aguzarov, AD; Antonenko, AР; Barna, IV; Bryun, EA; Duzhev, DV; Galaktionova, TE; Grishina, EA; Orlova, AV; Rozochkin, IN; Savchenko, LM; Skryabin, VY; Sorokin, AS; Sychev, DA; Zastrozhin, MS | 1 |
| Chobanu, IK; Israelian, AIu; Kost, NV; Medvedev, VE; Miasoedov, NF; Sokolov, OIu; Tereshchenko, ON | 1 |
| Chobanu, IK; Gushanskaya, EV; Kost, NV; Medvedev, VE; Myasoedov, NF; Sokolov, OY; Ter-Israelyan, AY; Tereshchenko, ON | 1 |
| Dorofeeva, OA; Mametova, LÉ; Neznamov, GG; Siuniakov, SA; Teleshova, ES | 1 |
| Gudasheva, TA; Kadnikov, IA; Kolik, LG; Seredenin, SB; Zhukov, VN | 1 |
| Nuller, YL | 1 |
2 trial(s) available for phenazepam and Anxiety Disorders
| Article | Year |
|---|---|
[A comparison of the anxiolytic effect and tolerability of selank and phenazepam in the treatment of anxiety disorders].
Topics: Adolescent; Adult; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Female; Humans; Male; Middle Aged; Oligopeptides; Young Adult | 2014 |
[Optimization of the treatment of anxiety disorders with selank].
Topics: Adolescent; Adult; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Drug Therapy, Combination; Female; Humans; International Classification of Diseases; Male; Middle Aged; Oligopeptides; Psychiatric Status Rating Scales; Quality of Life; Young Adult | 2015 |
6 other study(ies) available for phenazepam and Anxiety Disorders
| Article | Year |
|---|---|
Effects of
Topics: Adult; Alcoholism; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Cytochrome P-450 CYP2C19; Female; Genotype; Humans; Male | 2020 |
Effects of CYP2C19*17 polymorphisms on the efficacy and safety of bromodigyrochlorophenylbenzodiazepine in patients with anxiety disorder and comorbid alcohol use disorder.
Topics: Adult; Alcoholism; Anxiety Disorders; Benzodiazepines; Biotransformation; Cytochrome P-450 CYP2C19; Humans; Male; Polymorphism, Single Nucleotide; Psychiatric Status Rating Scales; Treatment Outcome | 2018 |
Using a personalized clinical decision support system for bromdihydrochlorphenylbenzodiazepine dosing in patients with anxiety disorders based on the pharmacogenomic markers.
Topics: Adult; Alcoholism; Anxiety Disorders; Benzodiazepines; Cytochrome P-450 CYP2C19; Decision Support Systems, Clinical; GABA Agents; Humans; Male; Middle Aged; Pharmacogenetics; Polymorphism, Single Nucleotide; Substance Withdrawal Syndrome | 2018 |
[Effect of phenazepam in various medicinal forms on psychophysical state of patients with anxiety disorders].
Topics: Administration, Cutaneous; Adolescent; Adult; Anxiety Disorders; Attention; Benzodiazepines; Dosage Forms; Female; Humans; Male; Middle Aged; Motor Activity; Reaction Time; Task Performance and Analysis | 2011 |
[Effect of GB-115 dipeptide on anxiety in rats with model benzodiazepine withdrawal syndrome].
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Animals, Outbred Strains; Anti-Anxiety Agents; Anxiety Disorders; Behavior, Animal; Benzodiazepines; Brain Chemistry; Diazepam; Dipeptides; Disease Models, Animal; Dopamine; Exploratory Behavior; Male; Maze Learning; Rats; Substance Withdrawal Syndrome; Tetragastrin; Tranquilizing Agents | 2011 |
Depersonalisation--symptoms, meaning, therapy.
Topics: Adult; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Benzodiazepinones; Bipolar Disorder; Clozapine; Depersonalization; Depressive Disorder; Diagnosis, Differential; Dibenzazepines; Female; Humans; Hypochondriasis; Male; Middle Aged | 1982 |